Skip to main content

Animations

MJFF Publications

4561 - 4570 of 6458 Results
Title
Year
  • Year
  • 2021
  • 2020
  • 2023
  • 2023
  • 2019
  • 2024
  • 2024
  • 2024
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design
    Journal Name: Contemporary Clinical Trials Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25897
    Citation Count: 110
  • Summary Details
    OPEN
    Title: Cell-free RNA signatures predict Alzheimer’s disease
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.isci.2023.108534
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson’s Disease
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s11481-023-10094-7
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Neurophysics Assessment of the Muscle Bioenergy Generated by Transcranial Magnetic Stimulation
    Journal Name: Research
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2019/7109535
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Single molecule array measures of LRRK2 kinase activity in serum link Parkinson’s disease severity to peripheral inflammation
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-024-00738-4
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
    Journal Name: Cell Death & Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41419-024-06534-8
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00830-y
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Interactions of Oligodendrocyte Precursor Cells and Dopaminergic Neurons in the Mouse Substantia Nigra
    Journal Name: Journal of Neurochemistry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/jnc.16298
    Citation Count: 9
  • Summary Details
    OPEN
    Title: iATPSnFR2: A high-dynamic-range fluorescent sensor for monitoring intracellular ATP
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2314604121
    Citation Count: 68
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.